The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

Autor: S. R. Hoyer, Judith G. Regensteiner, A. M. Jacobsen, P. Casanova, B. Clarke, K. B. Czech, P. O'Hara, M. Kocal, Pamela G. Watson, B. N. Calonge, M. L. Jeffirs, K. A. Smith, K. M. Callaghan, B. M. Kennedy, P. V. Nash, B. Van-Dorsten, J. Mendez, M. Quitingon, A. A. Hebert, H. Seagle, T. Franklin, F. G. Guillory, Donna H. Ryan, M. M. Rozek, K. A. Stepp, B. Harding-Clay, B. J. Goldstein, D. Williamson, J. J. Zachwieja, P. C. Vicknair, David A. Ehrmann, F. L. Greenway, J. Perault, Ronald B. Goldberg, M. Nicosia, P. Rowe, C. M. Mobley, L. E. Melancon, R. M. Hilbrich, R. T. Tulley, W. L. McNabb, M. A. Malloy, D. A. Collins, J. A. Tobian, L. M. Kula, J. T. Mendoza, H. J. Florez, Margaret J. Matulik, J. A. St. Amant, J. Ojito, S. C. Steinke, D. Schweizer, S. Rubtchinsky, A. R. Semenske, C. DeSandre, R. Liberoni, J. Pan, C. M. Champagne, R. P. Donahue, E. Caballero, George A. Bray, K. G. Smith, H. Miettinen, J. P. Burke, E. Tucker, Steven M. Haffner, M. Miller-Stone, James O. Hill, John Spandorfer, L. Testaverde, E. W. Seely, K. E. Lawton, Edward S. Horton, V. McLymont, O. P. Ganda, R. A. Arky, L. Dawson, B. T. Jortberg, I. W. Culbert, L. Murphy, L. A. Mykkanen, B. Eberhardt, J. Calles, A. Giannella, G. Geiger, C. Lark, M. Bryant, K. S. Polonsky, R. Prineas, L. H. Morris, D. A. Sanford, Jennifer C. Lovejoy, S. D. Jackson, Richard F. Hamman, L. L. Smith, C. Pepe, C. F. Oldmixon, Maria G. Montez

Publikováno v: Diabetes care. 23(11)

OBJECTIVE: The Diabetes Prevention Program (DPP) is a 27-center randomized clinical trial designed to evaluate the safety and efficacy of interventions that may delay or prevent development of diabetes in people at increased risk for type 2 diabetes.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd58ea95ca60d1d5b9d0abe070e5aa91
https://pubmed.ncbi.nlm.nih.gov/11092283

Hypoglycemia associated with liver disease and ethanol

Autor: R A, Arky

Publikováno v: Endocrinology and metabolism clinics of North America. 18(1)

The liver is key to glucose homeostasis. Any disruption of its metabolism, structural integrity, or intracellular dynamics may alter the liver's ability to maintain normal glucose homeostasis. When such disruption affects hepatic glucose output, hypo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::abdf34892a31cff33ea8979fff64182c
https://pubmed.ncbi.nlm.nih.gov/2645130

Glucagon induced refractoriness to exogenous mineralocorticoid

Autor: J T, O'Brian, C D, Saudek, R F, Spark, R A, Arky

Publikováno v: The Journal of clinical endocrinology and metabolism. 38(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ef9971a9d1cfe8efcc9efc34b85bf708
https://pubmed.ncbi.nlm.nih.gov/4831712

Changes in the disposition of alimentary fat induced by ethanol

Autor: D E, Wilson, R A, Arky

Publikováno v: Diabetes. 17

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9a20ce868525ba559921053de6dc6e78
https://pubmed.ncbi.nlm.nih.gov/5651728

Effects of fasting and refeeding. II. Tubular sites of sodium reabsorption and effects of oral carbohydrate on potassium, calcium and phosphate excretion

Autor: R S, Hoffman, J A, Martino, G, Wahl, R A, Arky

Publikováno v: The Journal of laboratory and clinical medicine. 74(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::23a173db3773c8ccd0a4df6fa9664f2a
https://pubmed.ncbi.nlm.nih.gov/5359664